These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3736675)

  • 41. Trans-platinum complexes as anticancer drugs: recent developments and future prospects.
    Radulovic S; Tesic Z; Manic S
    Curr Med Chem; 2002 Sep; 9(17):1611-8. PubMed ID: 12171556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes.
    Farrell N; Qu Y; Hacker MP
    J Med Chem; 1990 Aug; 33(8):2179-84. PubMed ID: 2374143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicity.
    Talebian AH; Bensely D; Schein PS; Green D
    Anticancer Drug Des; 1990 Nov; 5(4):371-8. PubMed ID: 2291775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
    Bierbach U; Sabat M; Farrell N
    Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo activity of two second generation platinum analogs in murine bladder cancer.
    Niell HB; Herrod HG; Blatnik AF; Soloway MS
    J Urol; 1985 Aug; 134(2):399-402. PubMed ID: 3894702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acute and subacute toxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in laboratory rodents].
    Härtl A; Güttner J; Horn U; Jelinek F; Stöckel U; Schröer HP; Hoffmann H
    Arch Geschwulstforsch; 1989; 59(4):239-44. PubMed ID: 2640563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The biological activity of platinum and methionine complexes: the antitumor action and inhibition of root growth by complexes of differing compositions and structures].
    Ivanov VB; Mogilevkina MF; Bystrova EI; Larina LP
    Izv Akad Nauk SSSR Biol; 1989; (3):469-73. PubMed ID: 2760334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)].
    Osieka R; Schmidt CG
    Klin Wochenschr; 1979 Dec; 57(23):1249-58. PubMed ID: 121143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Experimental pharmacologic and morphologic study of new platinum complexes].
    Karanvanova M; Getov Kh; Topashka-Ancheva M; Bakalova A; Cholakova I
    Eksp Med Morfol; 1989; 28(4):20-5. PubMed ID: 2627897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Platinum-based antineoplastic agents: biomedical applications and therapeutic aspects].
    Dominici C; Petrucci F; Alimonti A; La Torre F; Cifani A; Caroli S
    Ann Ist Super Sanita; 1995; 31(2):289-94. PubMed ID: 8561393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes.
    Khokhar AR; al-Baker S; Brown T; Perez-Soler R
    J Med Chem; 1991 Jan; 34(1):325-9. PubMed ID: 1992134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A review of selected cytostatic agents based on platinum].
    Hejl J; Kiss F; Hejlová N
    Vnitr Lek; 1985 Jun; 31(6):577-84. PubMed ID: 3898566
    [No Abstract]   [Full Text] [Related]  

  • 55. [Platinum compounds: metabolism, toxicity and supportive strategies].
    Lipp HP; Hartmann JT
    Praxis (Bern 1994); 2005 Feb; 94(6):187-98. PubMed ID: 15754530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane.
    Leopold WR; Batzinger RP; Miller EC; Miller JA; Earhart RH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4368-77. PubMed ID: 7030475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia.
    Richardson DR; Lovejoy DB
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1257-70. PubMed ID: 11060741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unusual DNA binding modes for metal anticancer complexes.
    Pizarro AM; Sadler PJ
    Biochimie; 2009 Oct; 91(10):1198-211. PubMed ID: 19344743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC; Borch RF
    Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nephrotoxicity and myelotoxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in rats].
    Horn U; Härtl A; Neuhaus G; Stöckel U; Schröer HP; Hoffmann H
    Arch Geschwulstforsch; 1989; 59(4):245-50. PubMed ID: 2802932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.